Big surprise, right?
[quote=http://sustainablepulse.com/2015/05/30/ ... o-disease/]“The modus operandi at FDA is to rubber stamp AquaBounty’s flawed and biased studies and then call its review process ‘science-based,’” said Jaydee Hanson, Senior Policy Analyst at the Center for Food Safety. “FDA’s inadequate risk assessment is at odds with reality, with science and with the public, which has long called on the agency to put consumers’ health and environmental safety ahead of the corporate interests of the biotechnology industry.”[/quote]
FrankenSalmon: Grows Slower, More Suspectible to Disease, Varied Performance
Moderator: Global Moderator
-
MachineGhost
- Executive Member
- Posts: 10054
- Joined: Sat Nov 12, 2011 9:31 am
FrankenSalmon: Grows Slower, More Suspectible to Disease, Varied Performance
Last edited by MachineGhost on Sun Jun 07, 2015 5:06 pm, edited 1 time in total.
"All generous minds have a horror of what are commonly called 'Facts'. They are the brute beasts of the intellectual domain." -- Thomas Hobbes
Disclaimer: I am not a broker, dealer, investment advisor, physician, theologian or prophet. I should not be considered as legally permitted to render such advice!
Disclaimer: I am not a broker, dealer, investment advisor, physician, theologian or prophet. I should not be considered as legally permitted to render such advice!
-
Libertarian666
- Executive Member
- Posts: 5994
- Joined: Wed Dec 31, 1969 6:00 pm
Re: FrankenSalmon: Grows Slower, More Suspectible to Disease, Varied Performance
I'm shocked, of course.MachineGhost wrote: Big surprise, right?
http://sustainablepulse.com/2015/05/30/canadian-risk-assessment-finds-gmo-salmon-susceptible-to-disease/ wrote:“The modus operandi at FDA is to rubber stamp AquaBounty’s flawed and biased studies and then call its review process ‘science-based,’” said Jaydee Hanson, Senior Policy Analyst at the Center for Food Safety. “FDA’s inadequate risk assessment is at odds with reality, with science and with the public, which has long called on the agency to put consumers’ health and environmental safety ahead of the corporate interests of the biotechnology industry.”